.png?width=1920&name=Bilder%20Blog%20and%20Landing%20Pages%20(1).png "Inside the Minds of Clinical Trial Physicians: Key Motivators, Challenges and Needs")
Wednesday, May 15, 2024 | 3:00 – 4:00 PM CET
Convincing trial physicians to participate in a clinical trial is an ongoing challenge for sponsors and CROs. For physicians, trials are burdensome on many levels including the time required, administrative hurdles and communications with sponsors and patients. Often, there is little academic merit waiting for them at the end. So it’s not surprising that physicians prefer to put their efforts elsewhere.
Yet, without trials, there is little scientific advancement and less chance to help patients with novel treatments. In this webinar, we were joined by former physician and former CSO of Novartis, Professor Lothar Färber to present exclusive findings from a recent survey conducted by Climedo and Siteworks among 65+ European trial physicians.
We uncovered key drivers for trial physicians to join a trial, the challenges they encounter, their expectations from sponsors and CROs and their perspectives on digital solutions in trials. We also covered several interesting open comments that physicians gave during the survey.
What we dicussed:
- Exclusive insights: Gain access to unique insights based on our recent survey findings.
- Interactive polls: Participate in interactive audience polls to share your thoughts and insights.
- Live discussion: Engage in a dynamic discussion with our panelists and fellow attendees and ask our expert Prof. Färber any questions you may have
This was an opportunity to gain valuable insights and contribute to the discussion on enhancing collaboration between trial physicians, sponsors, and CROs in clinical trials.
Meet Our Speakers
Bradley Fryer (Webinar Host)
Business Development Manager
Climedo
As a Business Development Manager at Climedo, Brad accompanies pharma and medtech customers on their journey to successful clinical trials in both late and post-approval phases. He advises companies on the use of Climedo's modular, hybrid and integrated EDC & eCOA/ePRO solutions to save time, boost efficiency and bring the best treatments to patients faster.
Catherine Higginson
Associate Director, Marketing & Communications | Climedo
As the Marketing & Communications Lead at Climedo and an aspiring EUPATI patient fellow, Catherine oversees the areas of industry research, content creation and collaboration with thought leaders and partners for marketing-related projects and events. She is passionate about showcasing the benefits of hybrid trials in the pharma and medtech industries.
Professor Lothar Färber
Professor
University of Regensburg
Lothar Färber is a pharmacology professor at Regensburg University, Germany. He held managerial roles at major pharmaceutical companies, including CSO at Novartis from 2008 to 2019. With over three decades of experience, he supervised 500+ clinical trials across various indications. He also holds an executive MBA from Harvard Business School, Boston and currently provides consultancy.
What was on the Agenda?
-
Intro (Bradley Fryer)
-
Inside the Minds of Clinical Trial Physicians: Key Motivators, Challenges and Needs
(Catherine Higginson and Prof. Lothar Färber) -
Discussion and networking (all)
- Wrap-up (Bradley Fryer)
Key Takeaways
INSIGHTS
Valuable insights into a trial physician's perspective on clinical research.
BEST PRACTICES
Key motivators for trial physicians, challenges they face, their expectations towards sponsors and CROs as well as their thoughts on digital solutions in trials.NETWORKING & DISCUSSION
Discussions with other industry professionals and learnings on how they are tackling challenges similar to yours.
CLIMEDO
The leading European eCOA system for non-interventional studies, RWE and launch success
Climedo offers an all-in-one eCOA and EDC solution with hybrid capabilities for non-interventional studies and real-world evidence. By using a patient-centric approach and leveraging real-time data insights and visualizations around a study’s current progress, Climedo empowers its clients to better engage with healthcare professionals and other key opinion leaders (KOLs). This boosts awareness, stimulates scientific dialogue and accelerates the launch success of new medical innovations, thus reaching more patients faster.
Founded in Munich in 2017, Climedo is a leading trusted partner for pharma, medtech, CROs and academia with over 1.7 million patients enrolled to date. Learn more at www.climedo.com.
